Evidence map›Paper›PMID 40496378›Full record

ArticlePublic health challenges2022

Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan.

Usman Abubakar Haruna, Oladunni Abimbola Amos, Dawa Gyeltshen, Paolo Colet, Joseph Almazan, Attaullah Ahmadi, Antonio Sarria-Santamera

Abstract read
In one paragraph

Article in Public health challenges, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Public Health Communication Challenges in Eastern Europe and Central Asia: A Scoping Review.International journal of environmental research and public health · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The COVID-19 pandemic and mental health in Kazakhstan.Global mental health (Cambridge, England) · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Usman Abubakar HarunaDepartment of Medicine Nazarbayev University School of Medicine (NUSOM) Nursultan Kazakhstan.ORCID https://orcid.org/0000-0002-9135-0473
Oladunni Abimbola AmosDepartment of Pharmacology and Therapeutics University of Ibadan, Ibadan, Oyo State Nigeria.ORCID https://orcid.org/0000-0002-6023-3725
Dawa GyeltshenDepartment of Medicine Jigme Dorji Wangchuk National Referral Hospital Thimphu Bhutan.
Paolo ColetDepartment of Medicine Nazarbayev University School of Medicine (NUSOM) Nursultan Kazakhstan.
Joseph AlmazanDepartment of Medicine Nazarbayev University School of Medicine (NUSOM) Nursultan Kazakhstan.
Attaullah AhmadiMedical Research Center Kateb University Kabul Afghanistan.ORCID https://orcid.org/0000-0001-6687-4526
Antonio Sarria-SantameraDepartment of Medicine Nazarbayev University School of Medicine (NUSOM) Nursultan Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kazakhstan announced the first cases of COVID-19 in March 2020. Within a span of a few months, the pandemic ravaged all regions affecting vulnerable populations due to limited access to healthcare services and co-morbidities. To minimize the spread of the pandemic, the government announced the implementation of containment measures such as quarantine, movement restrictions, and lockdowns among others. The collateral effect of the pandemic has disrupted economic and learning activities pushing several people below the poverty line. The pandemic revealed the weakness of healthcare including the acute shortage of essential medicines and lack of hospital beds. This calls for stringent measures to revive the economy and mitigate the reeling effect of the pandemic. As a result, Kazakhstan commenced COVID-19 vaccination efforts in February 2021. To date, about 47.8% are fully vaccinated pushing Kazakhstan closer to achieving herd immunity at the 60% threshold. However, the country faces challenges such as vaccine hesitancy and uncertainty surrounding vaccine effectiveness against new variants of SARS-CoV2, among others. This paper aims to explore the health and socioeconomic challenges caused by COVID-19 in Kazakhstan, control strategies, vaccination campaigns and progress towards herd immunity.

Indexed as

challengesCOVID‐19herd immunityKazakhstanpandemicvaccination

Identifiers

PMID40496378
PMCPMC12039651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.